Peer-reviewedCC BYFrontiers in cell and developmental biology
Efficacy and safety of bone marrow mononuclear cell therapy for myocardial infarction: a dose–response meta-analysis
- 1Department of Cardiology, Arteriosclerosis Cardiovascular Disease Clinical Medical Research Center of Hubei Province, Renmin Hospital, Hubei University of Medicine , ,
Related
- The heart-liver axis controls platelet turnover by hepatic STAT3 phosphorylation and TPO regulation after acute myocardial infarction
- Stress hyperglycemia impairs FOXK2-dependent macrophage cardiac repair after myocardial infarction
- Myocardial lipid remodeling in patients with myocardial infarction undergoing cardiac surgery
- Human iPSC models of myocardial infarction: From injury to repair and therapeutic discovery
- Cardiomyocyte-specific deletion of thioredoxin promotes myocardial injury, infarction and mitochondrial dysfunction: translocation of cytosolic thioredoxin into mitochondria rescue myocardial dysfunction by restoration of cardiac mitochondrial structure and function.
BibTeX
@article{tian2026efficacy,
title = {{Efficacy and safety of bone marrow mononuclear cell therapy for myocardial infarction: a dose–response meta-analysis}},
author = {Jianzhou Tian and Jianing Wang and Ziheng Cui and Cui Xie and Pei Qiao and Jun Shen},
journal = {Frontiers in cell and developmental biology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13690531},
note = {CC BY},
}
RIS
TY - JOUR
TI - Efficacy and safety of bone marrow mononuclear cell therapy for myocardial infarction: a dose–response meta-analysis
AU - Jianzhou Tian
AU - Jianing Wang
AU - Ziheng Cui
AU - Cui Xie
AU - Pei Qiao
AU - Jun Shen
PY - 2026
DA - 2026/10/24
JO - Frontiers in cell and developmental biology
UR - https://europepmc.org/article/PMC/PMC13690531
SN - 2296-634X
ER -